NEURELIS, INC.
Biopharmaceutical company specializing in treatments for neurological conditions.
The register keeps a separate record of this client for every firm that files for it and every spelling of its name. All 2 of its records are shown together here.
Reported lobbying by year
Filings
| Filing | Filed by | Amount |
|---|---|---|
|
Registration 4th Quarter 2024
|
ARNOLD & PORTER KAYE SCHOLER LLP | — reported |
Filed by
Each firm that has reported for this client, and the client itself where it lobbies in-house, with the reports filed and the amounts they disclose.
| Firm | Reports | Amount |
|---|---|---|
| ARNOLD & PORTER KAYE SCHOLER LLP | 8 | $90,000 |
| FEROX STRATEGIES | 1 | $40,000 |
Issues lobbied
How many report sections named each issue, counting the current version of each report.
| Issue | Code | Mentions |
|---|---|---|
| Health Issues | HCR | 7 |
| Medicare/Medicaid | MMM | 2 |
Bills named in its filings
Bill numbers found in the filers' descriptions, most often named first.
From reports filed under the Lobbying Disclosure Act. Firms report what each client paid them; an organisation lobbying for itself reports its own expenses. Amounts count the current version of each report once.